1.
Validation of standardized creatinine and cystatin C GFR estimating equations in a large multicentre European cohort of children
by Björk, Jonas
Pediatric nephrology (Berlin, West), 2019, Vol.34 (6), p.1087-1098
2.
Determination of iohexol by capillary blood microsampling and UHPLC-MS/MS
by Ion, Valentin
Journal of pharmaceutical analysis, 2019, Vol.9 (4), p.259-265
3.
Green urine
by Leclercq, Philippe, Dr
The Lancet (British edition), 2009, Vol.373 (9673), p.1462-1462
4.
Abnormal glomerular filtration rate in children, adolescents and young adults starts below 75 mL/min/1.73 m(2)
by Pottel, Hans
Pediatric nephrology (Berlin, West), 2015, Vol.30 (5), p.821-828
5.
Abnormal glomerular filtration rate in children, adolescents and young adults starts below 75 mL/min/1.73 m2
by Pottel, Hans
Pediatric nephrology (Berlin, West), 2014, Vol.30 (5), p.821-828
6.
Evaluation of the creatinine-based chronic kidney disease in children (under 25 years) equation in healthy children and adolescents
by Pottel, Hans
Pediatric nephrology (Berlin, West)
7.
Chronic kidney disease in Taiwan
by Delanaye, Pierre
The Lancet (British edition), 2008, Vol.372 (9654), p.1950-1950
8.
Abnormal glomerular filtration rate in children, adolescents and young adults starts below 75 mL/min/1.73 m.sup.2.(Original Article)
by Pottel, Hans
Pediatric nephrology (Berlin, West), 2015, Vol.30 (5), p.821
9.
Abnormal glomerular filtration rate in children, adolescents and young adults starts below 75 mL/min/1.73 m^sup 2
by Hans Pottel
Pediatric nephrology (Berlin, West), 2015, Vol.30 (5), p.821
10.
Glomerular Filtration Rate and Aging: Another Longitudinal Study - A Long Time Coming
by Delanaye, Pierre
Nephron (2015), 2015, Vol.131 (1), p.1-4
11.
Performance of creatinine and cystatin C-based glomerular filtration rate estimating equations in a European HIV-positive cohort
by GAGNEUX-BRUNON, Amandine
AIDS (London), 2013, Vol.27 (10), p.1573-1581
12.
Bone markers during acute burn care: Relevance to clinical practice?
by Rousseau, Anne-Françoise
Burns, 2016, Vol.43 (1), p.176-181
13.
The Third/Second Generation PTH Assay Ratio as a Marker for Parathyroid Carcinoma: Evaluation Using an Automated Platform
by Cavalier, Etienne
The journal of clinical endocrinology and metabolism, 2014, Vol.99 (3), p.E453-E457
14.
Effects of fibrates on cardiovascular outcomes
by Braillon, Alain
The Lancet (British edition), 2010, Vol.376 (9746), p.1051-1051
15.
Back pain and renal failure
by Delanaye, Pierre
The Lancet (British edition), 2004, Vol.364 (9449), p.1992-1992
16.
Fibroblast growth factor 23 in acute burn patients: Novel insights from an intact-form assay
by Rousseau, Anne-Françoise
Burns, 2016, Vol.42 (5), p.1082-1087
17.
Effects of fibrates on cardiovascular outcomes
by Delanaye, Pierre
The Lancet (British edition), 2010, Vol.376 (9746), p.1051-1051
18.
Paricalcitol for reduction of albuminuria in diabetes
by Fourtounas, Costas
The Lancet (British edition), 2011, Vol.377 (9766), p.636, author reply 636
19.
Paricalcitol for reduction of albuminuria in diabetes
by Delanaye, Pierre
The Lancet (British edition), 2011, Vol.377 (9766), p.635-635
20.
The Ratio of Parathyroid Hormone as Measured by Third- and Second-Generation Assays as a Marker for Parathyroid Carcinoma
by Cavalier, Etienne
The journal of clinical endocrinology and metabolism, 2010, Vol.95 (8), p.3745-3749
